Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.

PubWeight™: 2.44‹?› | Rank: Top 2%

🔗 View Article (PMID 2873550)

Published in Pain on May 01, 1986

Authors

R K Portenoy, K M Foley

Articles citing this

Guidelines for managing chronic non-malignant pain. Opioids and other agents. College of Physicians and Surgeons of Alberta. Can Fam Physician (1995) 3.45

Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med (2002) 3.20

Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med (2007) 1.89

Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend (2010) 1.89

Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81

Opioid therapy for chronic pain in the United States: promises and perils. Pain (2013) 1.69

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56

Dependence and addiction during chronic opioid therapy. J Med Toxicol (2012) 1.51

Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain (2010) 1.42

Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol (2008) 1.38

Model of scientific reasoning. Can Fam Physician (1995) 1.35

Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32

Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health (2014) 1.31

Endocannabinoid mechanisms of pain modulation. AAPS J (2006) 1.28

Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain (2009) 1.27

Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res (2013) 1.20

The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain (2014) 1.19

Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci (1998) 1.16

Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain (2010) 1.14

Gender differences in risk factors for aberrant prescription opioid use. J Pain (2009) 1.13

Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol (2013) 1.08

Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes (2008) 1.07

Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. PLoS One (2015) 1.06

The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry (2011) 1.04

Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J (2003) 0.99

A comprehensive approach to address the prescription opioid epidemic in Washington State: milestones and lessons learned. Am J Public Health (2015) 0.97

Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage (2008) 0.95

Chronic pain--challenge and response. Drugs (1994) 0.94

Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011. Am J Public Health (2014) 0.94

Safe opioid prescribing: a long way to go. J Gen Intern Med (2011) 0.88

Use and abuse of opioid analgesics in chronic pain. Can Fam Physician (1993) 0.87

Effect of long-term treatment of morphine on enzymes, oxidative stress indices and antioxidant status in male rat liver. Int J Clin Exp Med (2014) 0.86

Opioids in chronic noncancer pain: more faces from the crowd. Pain Res Manag (2012) 0.86

Policies and events affecting prescription opioid use for non-cancer pain among an insured patient population. Pain Physician (2014) 0.83

Management of chronic pain with chronic opioid therapy in patients with substance use disorders. Addict Sci Clin Pract (2013) 0.82

Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature. Curr Addict Rep (2015) 0.82

Dose escalation during the first year of long-term opioid therapy for chronic pain. Pain Med (2014) 0.81

Opioid pharmacotherapy for chronic noncancer pain: the american experience. Korean J Pain (2013) 0.80

The Decline in Hydrocodone/Acetaminophen Prescriptions in Emergency Departments in the Veterans Health Administration Between 2009 to 2015. West J Emerg Med (2016) 0.79

"Safe and effective when used as directed": the case of chronic use of opioid analgesics. J Med Toxicol (2012) 0.78

The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. J Clin Psychiatry (2014) 0.78

Management strategies for chronic pain. Ann Rheum Dis (1996) 0.77

The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain. Pain Res Manag (2010) 0.77

Nonoperative modalities to treat symptomatic cervical spondylosis. Adv Orthop (2011) 0.77

[Long-term application of opioids in chronic noncancer pain (LONTS 2): Urgently required new guidelines]. Schmerz (2015) 0.77

Effect of recombinant adenovirus coding for endomorphin-2 on neuropathic pain in rats. Int J Clin Exp Pathol (2012) 0.76

Herpes zoster management. Anesth Prog (1990) 0.75

Palliative medicine. Postgrad Med J (1993) 0.75

Physicians Experience with and Expectations of the Safety and Tolerability of WHO-Step III Opioids for Chronic (Low) Back Pain: Post Hoc Analysis of Data from a German Cross-Sectional Physician Survey. Pain Res Treat (2015) 0.75

Just say yes: the use of opioids for managing pain at the end of life. West J Med (1999) 0.75

Regulated analgesics and pain control. CMAJ (1996) 0.75

Three patients and their drugs: A parallel case paper on paediatric opiate use and withdrawal. Paediatr Child Health (2005) 0.75

Clinical Interventional Oncology Symposium And Integrative Healthcare Symposium. P T (2017) 0.75

Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Soc Sci Med (2017) 0.75

Articles by these authors

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07

Defining the clinically important difference in pain outcome measures. Pain (2000) 3.88

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62

Pain measurement: an overview. Pain (1985) 3.54

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27

The treatment of cancer pain. N Engl J Med (1985) 2.71

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage (1990) 2.48

The management of cancer pain. CA Cancer J Clin (1994) 2.41

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain (1990) 2.37

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain (1999) 2.09

Determinants of the willingness to endorse assisted suicide. A survey of physicians, nurses, and social workers. Psychosomatics (1997) 2.06

Competent care for the dying instead of physician-assisted suicide. N Engl J Med (1997) 1.94

The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85

Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol (1983) 1.74

A peaceful death: how to manage pain and provide quality care. A roundtable discussion: Part 2. Geriatrics (1996) 1.72

Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70

Pain and its persistence in herpes zoster. Pain (1996) 1.68

Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68

Pain relief into practice: rhetoric without reform. J Clin Oncol (1995) 1.64

Pain syndromes in multiple sclerosis. Neurology (1988) 1.63

The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer (1987) 1.57

Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage (1990) 1.52

Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48

Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47

Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain (1996) 1.46

The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med (1984) 1.46

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain (2001) 1.43

Central pain from cerebral abscess: thalamic syndrome in AIDS patients with toxoplasmosis. Neurology (1992) 1.42

The undertreatment of pain in ambulatory AIDS patients. Pain (1997) 1.40

Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care (1994) 1.38

Individual variability in the response to different opioids: report of five cases. Pain (1992) 1.36

Pain syndromes and etiologies in ambulatory AIDS patients. Pain (1997) 1.35

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27

A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage (2000) 1.22

Pain management in patients with pancreatic carcinoma. Cancer (1996) 1.20

Quality of life of women with ovarian cancer. Gynecol Oncol (1995) 1.19

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther (1992) 1.18

Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage (1990) 1.17

Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life. Pain (1996) 1.16

Responding to intractable terminal suffering. Ann Intern Med (2000) 1.16

End-of-life care: a survey of US neurologists' attitudes, behavior, and knowledge. Neurology (1999) 1.16

Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther (1988) 1.15

Headache in cerebrovascular disease. Stroke (1985) 1.14

Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care (1994) 1.14

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther (1987) 1.13

Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci (1986) 1.11

An anterior surgical approach to the upper thoracic vertebrae. J Neurosurg (1984) 1.10

The natural history of lumbosacral plexopathy in cancer. Neurology (1985) 1.09

Implementing national standards for cancer pain management: program model and evaluation. J Pain Symptom Manage (1996) 1.09

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer (1994) 1.08

Patterns of narcotic drug use in a cancer pain clinic. Ann N Y Acad Sci (1981) 1.06

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol (1998) 1.04

CT of the brachial plexus in patients with cancer. Neurology (1983) 1.04

Quality of life and survival: the role of multidimensional symptom assessment. Cancer (1998) 1.03

Radiation-induced malignant and atypical peripheral nerve sheath tumors. Ann Neurol (1980) 1.01

Opioid poorly-responsive cancer pain. Part 1: clinical considerations. J Pain Symptom Manage (2001) 1.00

The relationship of pain and symptom management to patient requests for physician-assisted suicide. J Pain Symptom Manage (1991) 1.00

I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep (1986) 1.00

Proposed classification of herpes zoster pain. Lancet (1994) 0.99

Palliative treatment of last resort and assisted suicide. Ann Intern Med (2000) 0.98

Palliative medicine: providing care when cure is not possible. A roundtable discussion: Part I. Geriatrics (1996) 0.98

Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol (1986) 0.98

Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol (2005) 0.98

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology (1993) 0.97

Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol (1992) 0.97

Does pseudotumor cerebri cause the empty sella syndrome? Neurology (1975) 0.97

Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid. J Pharm Sci (1983) 0.97

Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther (1990) 0.96

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology (1994) 0.95

Publication of papers on assisted suicide and terminal sedation. Ann Intern Med (2000) 0.95

Early seizures following intracerebral hemorrhage: implications for therapy. Neurology (1988) 0.95

Cancer pain management. Current strategy. Cancer (1993) 0.94

Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage (2000) 0.94

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer (1992) 0.93

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage (2001) 0.93

Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) (1998) 0.92

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain (1995) 0.92

Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther (1992) 0.92

Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manage (2001) 0.91

Opioid therapy for chronic nonmalignant pain: clinician's perspective. J Law Med Ethics (1996) 0.90

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer (1995) 0.90

Genetic study of cystic fibrosis of the pancreas using white blood cell cultures. Nature (1969) 0.90

Pain syndromes in patients with cancer. Med Clin North Am (1987) 0.90

Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clin Pharmacol Ther (1985) 0.88

Continuous intravenous infusion of opioid drugs. Med Clin North Am (1987) 0.88

Leukemic relapse presenting as sciatic nerve involvement by chloroma (granulocytic sarcoma). Cancer (1988) 0.87

Back pain in the cancer patient: an algorithm for evaluation and management. Neurology (1987) 0.87

White blood cell cultures in genetic studies on the human mucopolysaccharidoses. Science (1969) 0.86

Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr (1999) 0.86